Minor Breath Cannabinoids Were Not Detected in Every Early Sample
CBC and THCV showed promising early detection patterns, but neither was detected in every evaluated participant within the first hour. Their individual findings should not inherit the combined test’s reported 100% classification result.
The marker counts were specific
In the report’s table, CBC was detected in thirty-nine of forty participants within sixty minutes after smoking, while THCV was detected in thirty-six of forty. Neither was detected in the thirty-four available baseline assessments or the forty assessed beyond sixty minutes under the table’s conditions.
A combined rule can differ from a single marker
The proposed test used multiple cannabinoid findings and changes between breath samples. A successful combined classification therefore does not demonstrate that each component has perfect sensitivity. Absence in the baseline subset also does not establish universal specificity across every product, exposure history or time since use.
Keep the intended question narrow
The table concerns recovered breath markers after inhaled cannabis in the studied cohort. It does not validate detection after an edible, define all product compositions or independently classify driving performance. The small subsets, differing sampling schedules and lack of an independent driving reference limit the claim. The markers remain research findings that require their own performance characterization before broader forensic use.
Related analysis: the combined test’s validation limits.
Research cited
DeGregorio and colleagues (2021). A comprehensive breath test that confirms recent use of inhaled cannabis within the impairment window. DOI: 10.1038/s41598-021-02137-x.
